小智港股覆盤 | 6月7日
今日，港股三大指數集體下跌。截止收盤，恆生指數跌0.56%，報21531點。國企指數跌0.43%，報7467點。恆生科技指數跌0.05%，報4599點。市場約816只個股上漲，825只個股下跌。成交額突破1400.8億港幣，和昨天同期相比增長1.13%。南下資金淨流入12.44億港幣。
盤面上，綜合消費服務板塊全線走強。中教控股漲超20%；天立教育漲超17%；中彙集團漲超15%；希望教育漲超14%；新高教集團漲超11%。教育股大幅拉昇，中教控股漲13.93%；中彙集團午後漲超13%，機構看好應用型本科及職業教育學校長期發展。
互聯網醫療板塊暴漲。阿裏健康漲超7%；醫渡科技漲超3%；平安好醫生漲超1%。大和降阿裏健康目標價72%至4.2港元，下調至“持有”評級。
CRO板塊走高。泰格醫藥漲超6%；康龍化成漲超4%；藥明康德漲超3%；藥明生物、昭衍新藥等多股漲超2%。泰格醫藥升7%，前5個月IND處於相對高位，機構指公司在手訂單飽滿高增長確定性強；康龍化成公佈2022年A股限制性股票激勵，計劃授出154.88萬股限制性股票；藥明康德：A股將於6月9日派現金紅利每股0.5174元人民幣。
媒體板塊跌幅居前。樂享集團跌超35%；貝森金融跌超9%；文化傳信跌超8%；毛記葵涌、鳳凰衛視等多股跌超5%。樂享集團續漲逾7%創近一年來新高，一季度海外電商業務營收環比增長245.97%至5.12億港元。
電子板塊走低。瑞遠智控跌超20%；榮陽實業跌超10%；弘浩國際控股跌超7%；阿爾法企業、舜宇光學科技等多股跌超5%。
包裝印刷板塊走弱。硅鑫集團跌超18%；冠均國際控股跌超11%；順泰控股跌超4%；透雲生物跌超3%；嘉耀控股跌超2%。順泰控股附屬授出最多5500萬元人民幣貸款。
uSMART智能寫手的信息、數據均來自媒體公開報道，智能寫手不能保證其完全準確，內容僅供參考，不構成投資建議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
